Enact Holdings, Inc. ACT
46.97
(0.28)
(0.59%)
as of 25 Sep
- Market cap
- $6.5B
- P/E
- 9.8×
Follow ACT
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 12.87% | 12.93% | 13.03% | 12.75% |
+8 more TTM periods Free account |
|
| 9.95% | 9.88% | 10.05% | 9.79% | ||
ROIC |
9.51% | 9.71% | 9.73% | 9.56% | |
Return on Tangible Assets |
(415.32%) | (853.76%) | (1,900.03%) | (869.79%) | |
Average Days of Receivables |
19.41 | 13.94 | 13.62 | 14.50 | |
Free Cash Flow per Share |
5.17 | 5.10 | 4.88 | 4.78 | |
Free Cash Flow |
720.83 | 721.83 | 724.52 | 704.38 | |
Piotroski F-Score |
4.00 | 4.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
10.94% | 10.88% | 10.84% | 10.66% | |
Accounts Receivable Turnover |
22.64 | 26.45 | 24.93 | 25.13 | |
Accounts Payable Turnover |
0.49 | 0.48 | 0.49 | 0.50 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
755.69 | 767.26 | 762.62 | 757.20 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.21) | (0.21) | (0.21) | (0.22) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.70% | 0.72% | 0.74% | 0.78% | |
Share Based Compensation of Revenue |
1.65% | 1.64% | 1.54% | 1.47% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.06 | 1.07 | 1.07 | 1.07 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
8.99 | 8.77 | 8.33 | 8.31 | |
Operating CF per Share |
5.17 | 5.10 | 4.88 | 4.78 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
54.51% | 54.49% | 54.56% | 53.87% |
Columns are period end dates